Inflammatory bowel disease and associated cardiovascular disease outcomes: A systematic review

Vikash Jaiswal1, Nitya Batra2, Mehak Dagar3

  • 1Larkin Community Hospital, South Miami, FL.

Medicine
|February 23, 2023
PubMed

Insights

Patients with inflammatory bowel disease (IBD) face increased risks of cardiovascular disease (CVD) events and mortality, particularly women. Lifestyle changes like improved nutrition and exercise are key for CVD prevention in IBD patients.

Area of Science:

  • Cardiology
  • Gastroenterology
  • Public Health

Background:

  • Limited and conflicting data exist on cardiovascular disease (CVD) outcomes in inflammatory bowel disease (IBD) patients.
  • IBD encompasses chronic inflammatory conditions like ulcerative colitis (UC) and Crohn's disease (CD).
  • Understanding IBD's impact on cardiovascular health is crucial for patient management.

Approach:

  • A systematic literature review was conducted using major databases (PubMed, Embase, Cochrane, Scopus) up to May 2022.
  • Included 16 studies encompassing 2,029,941 patients with IBD.
  • Analyzed cardiovascular outcomes, mortality, risk factors, and comorbidities in the IBD population.

Key Points:

  • IBD patients exhibit higher risks for adverse cardiovascular outcomes, including myocardial infarction, heart failure, and stroke.
  • Common comorbidities in IBD patients include hypertension, diabetes mellitus, dyslipidemia, and previous CVD.
  • Smoking and alcohol consumption were identified as prevalent risk factors for CVD in this cohort.

Conclusions:

  • Inflammatory bowel disease is associated with an elevated risk of cardiovascular events and mortality, especially in female patients.
  • Current treatment lacks specific algorithms for assessing and managing CVD risk in IBD.
  • Prioritizing nutritional modifications and physical activity is essential for cardiovascular disease prevention in individuals with IBD.
Abstract

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
265
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
331
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
514
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
65
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
384
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
169